| Title | Critical Reviews in Oncology/Hematology |
| Abbreviation | Crit. Rev. Oncol./Hematol. |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Geriatrics and Gerontology (Q1); Hematology (Q1); Oncology (Q1) |
| h-index | 144 |
| Overall Rank/Ranking | 2083 |
| SCImago Journal Rank (SJR) | 1.572 |
| Impact Score | 5.58 |
| Publisher | Elsevier Ireland Ltd |
| Country | Ireland |
| ISSN | 10408428, 18790461 |
| Best Quartile | Q1 |
| Coverage History | 1983-2023 |
Critical Reviews in Oncology/Hematology publishes scholarly, critical reviews in all fields of oncology and hematology, and reviews and original research articles in the field of geriatric oncology. Most of the reviews are written on invitation. All reviews and original research articles are subject to peer review before final acceptance.Authors who wish to submit reviews to the journal are requested to submit a short synopsis of their chosen subject to the Editor, and to indicate the deadline by which they expect to submit their final manuscript. Authors of original research articles are requested to submit their manuscripts directly to the Editor.
Critical Reviews in Oncology/Hematology is a journal covering the technologies/fields/categories related to Geriatrics and Gerontology (Q1); Hematology (Q1); Oncology (Q1). It is published by Elsevier Ireland Ltd. The overall rank of Critical Reviews in Oncology/Hematology is 2083. According to SCImago Journal Rank (SJR), this journal is ranked 1.572. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 144. The best quartile for this journal is Q1.
The ISSN of Critical Reviews in Oncology/Hematology journal is 10408428, 18790461. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Critical Reviews in Oncology/Hematology is cited by a total of 3733 articles during the last 3 years (Preceding 2023).
The Impact IF 2023 of Critical Reviews in Oncology/Hematology is 5.58, which is computed in 2024 as per its definition. Critical Reviews in Oncology/Hematology IF is decreased by a factor of 0.27 and approximate percentage change is -4.62% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2023 of Critical Reviews in Oncology/Hematology is 5.58. If the same downward trend persists, Impact IF may fall in 2024 as well.
| Year | Impact IF |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 5.58 |
| 2022 | 5.85 |
| 2021 | 6.30 |
| 2020 | 5.74 |
| 2019 | 6.19 |
| 2018 | 5.58 |
| 2017 | 4.93 |
| 2016 | 5.37 |
| 2015 | 5.84 |
| 2014 | 4.56 |
Critical Reviews in Oncology/Hematology has an h-index of 144. It means 144 articles of this journal have more than 144 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Critical Reviews in Oncology/Hematology is 10408428, 18790461. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Critical Reviews in Oncology/Hematology is 2083. According to SCImago Journal Rank (SJR), this journal is ranked 1.572. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 1.572 |
| 2022 | 1.510 |
| 2021 | 1.478 |
| 2020 | 2.084 |
| 2019 | 2.213 |
| 2018 | 1.791 |
| 2017 | 1.710 |
| 2016 | 1.988 |
| 2015 | 1.851 |
| 2014 | 1.863 |
| Year | Ranking |
|---|---|
| 2023/2024 | Coming Soon |
| 2023 | 2083 |
| 2022 | 2110 |
| 2021 | 2141 |
| 2020 | 1224 |
| 2019 | 1102 |
| 2018 | 1655 |
| 2017 | 1807 |
| 2016 | 1414 |
| 2015 | 1674 |
| 2014 | 1595 |
Critical Reviews in Oncology/Hematology is published by Elsevier Ireland Ltd. It's publishing house is located in Ireland. Coverage history of this journal is as following: 1983-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Critical Reviews in Oncology/Hematology is Crit. Rev. Oncol./Hematol.. This abbreviation ('Crit. Rev. Oncol./Hematol.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Geriatrics and Gerontology (Q1); Hematology (Q1); Oncology (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Critical Reviews in Oncology/Hematology latest impact IF is 5.58. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 6.30 (2021) and 4.56 (2014), respectively, in the last 10 years. Moreover, its average IS is 5.59 in the previous 10 years.
The Critical Reviews in Oncology/Hematology has an SJR (SCImago Journal Rank) of 1.572, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 2.213 in 2019 and the lowest being 1.478 in 2021. Furthermore, the average SJR of the Critical Reviews in Oncology/Hematology over the previous 10-year period stands at 5.59.
The latest h-index of the Critical Reviews in Oncology/Hematology is 144.
The Critical Reviews in Oncology/Hematology is published by the Elsevier Ireland Ltd, with its country of publication being the Ireland.
The Critical Reviews in Oncology/Hematology is currently ranked 2083 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1102 in 2019 and its lowest position of 2141 in 2021.
The standard ISO4 abbreviation for the Critical Reviews in Oncology/Hematology is Crit. Rev. Oncol./Hematol..
Critical Reviews in Oncology/Hematology is classified as a journal that the Elsevier Ireland Ltd publishes.
The Critical Reviews in Oncology/Hematology encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Critical Reviews in Oncology/Hematology is assigned the following International Standard Serial Numbers (ISSN): 10408428, 18790461.
The best quartile for the Critical Reviews in Oncology/Hematology is Q1 (2023).
The Critical Reviews in Oncology/Hematology coverage history can be summarized as follows: 1983-2023.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Zeitschrift fur Germanistische Linguistik | journal | 14988 | Walter de Gruyter GmbH | 16 | 0.40 |
| SPE Production and Operations Symposium, Proceedings | conference and proceedings | 15907 | 21 | 0.00 | |
| Journal of Supply Chain Management | journal | 587 | Wiley-Blackwell | 112 | 12.51 |
| Transnational Corporations | journal | 11181 | UNCTAD United Nations Conference on Trade and Development | 28 | 1.83 |
| Built Environment | journal | 12809 | Alexandrine Press | 46 | 1.18 |
| Epigenetics | journal | 3529 | Landes Bioscience | 111 | 3.22 |
| Acta Periodica Technologica | journal | 23723 | University of Novi Sad, Faculty of Technology | 21 | 0.31 |
| Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria | journal | 25905 | National Association of Resident Doctors of Nigeria | 25 | 0.00 |
| Consulting engineer Barrington | journal | 24079 | Cahners Pub. Co. | 0 | 0.00 |
| Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining | conference and proceedings | 4334 | 192 | 0.00 |
| Year | Impact Score (IS) |
|---|---|
| 2024/2025 | Coming Soon |
| 2023 | 5.58 |
| 2022 | 5.85 |
| 2021 | 6.30 |
| 2020 | 5.74 |
| 2019 | 6.19 |
| 2018 | 5.58 |
| 2017 | 4.93 |
| 2016 | 5.37 |
| 2015 | 5.84 |
| 2014 | 4.56 |
